GRFS NASDAQ · Healthcare · FY 2025-12-31

Grifols SA

Back to NASDAQ
0.02.75.58.211.0ABVnot valid for this companyEPVfair 0.25buy ≤ 0.14EBVfair 10.14buy ≤ 4.56DBVfair 0.68buy ≤ 0.37price 6.91 EUR
0.03.16.29.412.5ABVnot valid for this companyEPVfair 0.28buy ≤ 0.15EBVfair 11.55buy ≤ 5.20DBVfair 0.77buy ≤ 0.43price 7.87 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in EURUSD
Verdict
Wait
Buy zone
Fair–Wait
Archetype
Asset-Light Compounder
Confidence
●●● High · 3/4
Price
6.9117.870 EURUSD *
Market cap
4.70B5.36B EURUSD *
P / B
0.89
P / E
11.71
EPS
0.5900.672
DPS / yield
0.0830.094 (1.2%)
NAV / share
-2.877-3.276
Graham number
10.14011.546
Z'' score
1.93
Piotroski F
5 / 9
Beneish M
-2.80
ROIC vs WACC
6.9% vs 7.3%

* Listed in USD — the pipeline states price and all valuations in the filing currency EUR (fx 0.88 EUR/USD).

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.